Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

NCT00066846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: fluorouracil
DRUG: leucovorin calcium

Sponsor

National Cancer Institute (NCI)